cabergoline has been researched along with calcium gluconate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elshaer, HS; Farouk, M; Fouda, UM; Hanafy, A; Mehrem, WM; Nabil, H; Youssef, GG; Youssef, MA | 1 |
| Karakus, C; Ozyurt, R; Turktekin, N | 1 |
1 trial(s) available for cabergoline and calcium gluconate
| Article | Year |
|---|---|
Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study.
Topics: Adult; Cabergoline; Calcium Gluconate; Female; Fertilization in Vitro; Humans; Incidence; Infusions, Intravenous; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Single-Blind Method; Treatment Outcome | 2022 |
1 other study(ies) available for cabergoline and calcium gluconate
| Article | Year |
|---|---|
Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome.
Topics: Cabergoline; Calcium Gluconate; Dopamine Agonists; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate | 2022 |